Accuracy Evaluation of the BD FACS Presto System

Becton, Dickinson and Company (BD)

Status: Completed

Conditions: Acquired Immunodeficiency Syndrome

Treatments: Device: BD FACSCalibur flow cytometer; Device: Investigational BD FACSPresto System; Device: Sysmex hematology analyzer KX-21

Study type: Observational

Funder types: Industry

Identifiers

NCT02396355

CAS-PCACC1

Details and patient eligibility

About

The enumeration of T lymphocytes positive for the CD4 antigen is used to determine the immune status of patients with, or suspected of developing, immune deficiencies such as AIDS. The BD FACS Presto™ is an investigational automated system for in vitro diagnostic use in performing the direct enumeration of CD4 absolute count, CD4 percentage of lymphocytes, and hemoglobin (Hb) concentration in human whole blood.

This is a prospective study to determine the relative bias between the investigational BD FACS Presto system and the predicate BD FACS Calibur with BD Tritest system in their determination of absolute CD4, % CD4, and Hb concentrations.

Enrollment: 583 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Subject has been infected with HIV and willing to provide informed consent to draw venous and capillary blood
• Specimen: Venous blood must be collected in blood collection tube with EDTA anticoagulant and stored at room temperature (20-25 °C) according to tube manufacturer's instructions
• Specimen: post enrolment staining within 24 hours
• venous blood of acceptable quality for flow cytometry, e.g. no hemolysis or clots and acceptable pre analytical handling)
• venous blood sample > 1 mL for sample preparation
• capillary blood applied to the investigational CD4/%CD4/Hb cartridge

Exclusion criteria

• Subject unwilling to disclose medical information regarding previous CD4 test results
• Subject unwilling to discuss medical information regarding co-morbid conditions and current medications

Trial design

583 participants in 1 patient group

All subjects

Description:

This is a single arm study. Samples from each subject will be tested with the Investigational BD FACSPresto System, the BD FACSCalibur flow cytometer, and the Sysmex hematology analyzer KX-21.

Treatment:

Device: Sysmex hematology analyzer KX-21

Device: BD FACSCalibur flow cytometer

Device: Investigational BD FACSPresto System